Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Cartesian Therapeutics Inc.
RNACCurrent price
17.02 USD
+0.22 USD (+1.31%)
Last closed
17.12 USD
Company
–
ISIN
US8162121045
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Capitalization
496 091 360 USD
Yield for 12 month
+16.98 %
1Y
3Y
5Y
10Y
15Y
RNAC
Cartesian Therapeutics, Inc., a clinical-stage biotechnology company, engages in the provision of mRNA cell therapies for the treatment of autoimmune diseases. It develops Descartes-08, an autologous anti-BCMA RNA-engineered chimeric antigen receptor T-cell therapy, currently under Phase 2b clinical development for generalized myasthenia gravis, as well as for patients with systemic lupus erythematosus, and myeloma autoimmune basket trials for other autoimmune diseases. The company develops Descartes-15 to treat Autoimmune diseases, myeloma; and Descartes-33 which is in preclinical development for treatment of autoimmune diseases. Cartesian Therapeutics, Inc. is headquartered in Gaithersburg, Maryland. Address: 704 Quince Orchard Road, Gaithersburg, MD, United States, 20878
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
43 USDP/E ratio
–Dividend Yield
–Current Year
+26 004 000 USD
Last Year
+110 777 000 USD
Current Quarter
+5 840 000 USD
Last Quarter
+5 840 000 USD
Current Year
+24 451 000 USD
Last Year
+108 740 000 USD
Current Quarter
+5 657 000 USD
Last Quarter
+5 657 000 USD
Key Figures RNAC
1 year
3 years
5 years
10 years
EBITDA
-39 761 000 USD
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-10.95 %
PEG Ratio
–
Return On Equity TTM
-7029.26 %
Wall Street Target Price
43 USD
Revenue TTM
47 938 000 USD
Book Value
0.031 USD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
-94.1 %
Dividend Yield
–
Gross Profit TTM
38 400 000 USD
Earnings per share
-47.22 USD
Diluted Eps TTM
-47.22 USD
Most Recent Quarter
II 2024
Quarterly Earnings Growth YOY
53.7 %
Profit Margin
–
Dividend Analytics RNAC
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History RNAC
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
1:30
Payout Ratio
–
Last Split Date
05.04.2024
Dividend Date
–
Stock Valuation RNAC
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
25.4453
Enterprise Value Revenue
7.8321
Price Sales TTM
10.3486
Enterprise Value EBITDA
-1.1711
Price Book MRQ
31.2575
Financials RNAC
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators RNAC
For 52 weeks
11.67 USD
42.6 USD
50 Day MA
18.85 USD
Shares Short Prior Month
2 056 590
200 Day MA
20.17 USD
Short Ratio
15.36
Shares Short
1 944 921
Short Percent
13.47 %
BeatStart